PharmaSGP Holding SE (PSG) — Cash Flow Reinvestment Rate
PharmaSGP Holding SE (PSG) has a Cash Flow Reinvestment Rate of 0.34x as of March 2025, reinvesting €1.42 Million (capex €708.00K plus investments €-708.00K) from operating cash flow of €4.22 Million. See PharmaSGP Holding SE free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmaSGP Holding SE Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for PharmaSGP Holding SE across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of PharmaSGP Holding SE.
Annual Cash Flow Reinvestment Rate for PharmaSGP Holding SE (2014–2024)
Year-by-year capital reinvestment analysis for PharmaSGP Holding SE. See financial flexibility index of PharmaSGP Holding SE to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | €2.94 Million | €24.88 Million | €1.47 Million | ▲ +82.0% |
| 2023 | 0.07x | €1.73 Million | €26.64 Million | €866.00K | ▲ +77.2% |
| 2022 | 0.04x | €907.00K | €24.71 Million | €120.00K | ▼ -99.5% |
| 2021 | 6.83x | €83.55 Million | €12.24 Million | €94.00K | ▲ +7906.1% |
| 2020 | 0.09x | €1.32 Million | €15.46 Million | €420.00K | ▲ +102.1% |
| 2019 | 0.04x | €744.00K | €17.63 Million | €420.00K | ▲ +29.8% |
| 2018 | 0.03x | €274.00K | €8.43 Million | €274.00K | ▼ -45.4% |
| 2017 | 0.06x | €848.00K | €14.25 Million | €397.00K | ▼ -98.6% |
| 2016 | 4.35x | €15.43 Million | €3.55 Million | €11.88 Million | ▲ +914.8% |
| 2015 | 0.43x | €4.54 Million | €10.59 Million | €4.26 Million | ▼ -35.7% |
| 2014 | 0.67x | €3.60 Million | €5.41 Million | €2.01 Million | — |